Maitrayee Chatterjee

Maitrayee Chatterjee

Auto-generated profile, based on publicly available information

Maitrayee Chatterjee

Utrecht University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2020 in mBio
Verified
Journal Article
Open access
PDF file
MCMaitrayee Chatterjee
Maitrayee Chatterjee
JPJos P M Van Putten
Jos P M Van Putten
KSKarin Strijbis
Karin Strijbis
Mucus plays a pivotal role in protecting the respiratory tract against microbial infections. It acts as a primary contact site to entrap microbes and facilitates their removal from the respiratory tract via the coordinated beating of motile cilia. The major components of airway mucus are heavily O -glycosylated mucin glycoproteins, divided into gel-forming mucins and transmembrane mucins. The gel-forming mucins MUC5AC and MUC5B are the primary structural components of airway mucus, and they enable efficient clearance of pathogens by mucociliary clearance.

10 August 2023 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MCMaitrayee Chatterjee
Maitrayee Chatterjee
LHLiane Z. X. Huang
Liane Z. X. Huang
AMAnna Z. Mykytyn
Anna Z. Mykytyn
CWChunyan Wang
Chunyan Wang
MLMart M. Lamers
Mart M. Lamers
KSKarin Strijbis
Karin Strijbis
Mucins play an essential role in protecting the respiratory tract against microbial infections while also acting as binding sites for bacterial and viral adhesins. The heavily O-glycosylated gel-forming mucins MUC5AC and MUC5B eliminate pathogens by mucociliary clearance. Transmembrane mucins MUC1, MUC4, and MUC16 can restrict microbial invasion at the apical surface of the epithelium. In this study, we determined the impact of host mucins and mucin glycans on epithelial entry of SARS-CoV-2. Human lung epithelial Calu-3 cells express the SARS-CoV-2 entry receptor ACE2 and high levels of glycosylated MUC1, but not MUC4 and MUC16, on their cell surface. The O-glycan-specific mucinase StcE specifically removed the glycosylated part of the MUC1 extracellular domain while leaving the underlying SEA domain and cytoplasmic tail intact. StcE treatment of Calu-3 cells significantly enhanced infection with SARS-CoV-2 pseudovirus and authentic virus, while removal of terminal mucin glycans sialic acid and fucose from the epithelial surface did not impact viral entry. In Calu-3 cells, the transmembrane mucin MUC1 and ACE2 are located to the apical surface in close proximity and StcE treatment results in enhanced binding of purified spike protein. Both MUC1 and MUC16 are expressed on the surface of human organoid-derived air-liquid interface (ALI) differentiated airway cultures and StcE treatment led to mucin removal and increased levels of SARS-CoV-2 replication. In these cultures, MUC1 was highly expressed in non-ciliated cells while MUC16 was enriched in goblet cells. In conclusion, the glycosylated extracellular domains of different transmembrane mucins might have similar protective functions in different respiratory cell types by restricting SARS-CoV-2 binding and entry.

23 December 2024 in Gut Microbes
Verified
Journal Article
Open access
EFEvelien Floor
Evelien Floor
JSJinyi Su
Jinyi Su
MCMaitrayee Chatterjee
Maitrayee Chatterjee
EKElise S. Kuipers
Elise S. Kuipers
NINoortje Ijssennagger
Noortje Ijssennagger
KSKarin Strijbis
Karin Strijbis
The intestinal mucosal barrier is a dynamic system that allows nutrient uptake, stimulates healthy microbe-host interactions, and prevents invasion by pathogens. The mucosa consists of epithelial cells connected by cellular junctions that regulate the passage of nutrients covered by a mucus layer that plays an important role in host-microbiome interactions. Mimicking the intestinal mucosa for in vitro assays, particularly the generation of a mucus layer, has proven to be challenging. The intestinal cell-line Caco-2 is widely used in academic and industrial laboratories due to its capacity to polarize, form an apical brush border, and reproducibly grow into confluent cell layers in different culture systems. However, under normal culture conditions, Caco-2 cultures lack a mucus layer. Here, we demonstrate for the first time that Caco-2 cultures can form a robust mucus layer when cultured under air-liquid interface (ALI) conditions on Transwell inserts with addition of vasointestinal peptide (VIP) in the basolateral compartment. We demonstrate that unique gene clusters are regulated in response to ALI and VIP single stimuli, but the ALI-VIP combination treatment resulted in a significant upregulation of multiple mucin genes and proteins, including secreted MUC2 and transmembrane mucins MUC13 and MUC17. Expression of tight junction proteins was significantly altered in the ALI-VIP condition, leading to increased permeability to small molecules. Commensal Lactiplantibacillus plantarum bacteria closely associated with the Caco-2 mucus layer and differentially colonized the surface of the ALI cultures. Pathogenic Salmonella enterica were capable of invading beyond the mucus layer and brush border. In conclusion, Caco-2 ALI-VIP cultures provide an accessible and straightforward way to culture an in vitro intestinal mucosal model with improved biomimetic features. This novel in vitro intestinal model can facilitate studies into mucus and epithelial barrier functions and in-depth molecular characterization of pathogenic and commensal microbe-mucus interactions.

29 October 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
MCMaitrayee Chatterjee
Maitrayee Chatterjee
LHLiane Z.X. Huang
Liane Z.X. Huang
AMAnna Z. Mykytyn
Anna Z. Mykytyn
CWChunyan Wang
Chunyan Wang
MLMart M. Lamers
Mart M. Lamers
KSKarin Strijbis
Karin Strijbis
Mucins play an essential role in protecting the respiratory tract against microbial infections but can also serve as binding sites for bacterial and viral adhesins. The heavily O -glycosylated gel-forming mucins MUC5AC and MUC5B eliminate pathogens by mucociliary clearance while transmembrane mucins MUC1, MUC4, and MUC16 can restrict microbial invasion at the apical surface of the epithelium. In this study, we determined the impact of host mucins and mucin glycans on SARS-CoV-2 epithelial entry. Human lung epithelial Calu-3 cells express the SARS-CoV-2 entry receptor ACE2 and high levels of glycosylated MUC1, but not MUC4 and MUC16, on their cell surface. The O -glycan-specific mucinase StcE specifically removed the glycosylated part of the MUC1 extracellular domain while leaving the underlying SEA domain and cytoplasmic tail intact. StcE treatment of Calu-3 cells significantly enhanced infection with SARS-CoV-2 pseudovirus and authentic virus, while removal of sialic acid and fucose from the epithelial surface did not impact viral entry. Both MUC1 and MUC16 are expressed on the surface of human air-liquid interface (ALI) differentiated airway organoids and StcE treatment led to mucin removal and increased levels of SARS-CoV-2 entry and replication. On the surface of Calu-3 cells, the transmembrane mucin MUC1 and ACE2 are often co-expressed and StcE treatment results in enhanced binding of purified spike protein and SARS-CoV-2 pseudovirus. This study points at an important role for glycosylated mucin domains as components of the host defense that can restrict SARS-CoV-2 infection. Author summary: SARS-CoV-2, the virus that has caused the devastating COVID-19 pandemic, causes a range of symptoms in infected individuals, from mild respiratory illness to acute respiratory distress syndrome. A fundamental understanding of host factors influencing viral entry is critical to elucidate SARS-CoV-2–host interactions and identify novel therapeutic targets. In this study, we investigated the role of host mucins and mucin glycans on SARS-CoV-2 entry into the airway epithelial cells. Mucins are a family of high molecular weight O -glycosylated proteins that play an essential role in protecting the respiratory tract against viral and bacterial infections. The gel-forming mucins MUC5AC and MUC5B clear pathogens by mucociliary clearance while transmembrane mucins MUC1, MUC4, and MUC16 can restrict or facilitate microbial invasion at the apical surface of the epithelium. The mucin-selective protease StcE specifically cleaves the glycosylated extracellular part of the mucins without perturbing the underlying domains. We show that removal of mucins from the surface of Calu-3 cells and primary airway epithelial cultures with StcE mucinase increases binding of the SARS-CoV-2 spike protein to the respiratory surface and greatly enhances infection. This study demonstrates the important role of glycosylated extracellular mucin domains as a host defense mechanism during SARS-CoV-2 entry. Future efforts should be focused on characterizing the role of specific soluble and transmembrane mucins during the different stages of SARS-CoV-2 infection.

16 July 2025 in bioRxiv
Verified
Preprint
Open access
SRSjoerd Ruizenaar
Sjoerd Ruizenaar
KLKatja Lange
Katja Lange
OHOlaf Heckert
Olaf Heckert
JLJan Lelieveld
Jan Lelieveld
AHAndrei Hrynevich
Andrei Hrynevich
MCMaitrayee Chatterjee
Maitrayee Chatterjee
The mucus layer lining the epithelium of the colon contains a microbiome that is distinct from the luminal microbiome; this is referred to as the mucus-associated microbiome (MAM). Recently, research on the MAM has gained momentum due to its significant role in immune and metabolic health. However, the study of the MAM is limited by conventional experimental techniques, as sampling this microbiome often requires invasive procedures, making in vivo research challenging. Additionally, obtaining samples from the MAM can compromise the lumen, complicating simultaneous studies of both the MAM and the lumen. To address these limitations, we present the TIM-2 muc , an advanced version of the colonic in vitro model TIM-2, which includes a mucus compartment comprising both colonic mucus beads - Gut 3 Beads and an electrospun sheet coated with Gut 3 Gel. To validate whether the integrated mucus compartment behaves like the in vivo MAM, we examined the bacterial composition, alpha and beta diversity, and the MAM’s composition compared to the lumen compartment of both the TIM-2 muc and the conventional TIM-2 model. Our findings suggest that the MAM in the TIM-2 muc model closely resembles its in vivo counterpart, thereby enhancing the physiological relevance of the luminal microbiome. TIM-2 muc , an advanced TIM-2 model, presents a novel, precise, standardized, and non-invasive method for studying the MAM and LM simultaneously.